Actinogen Medical (ACW) Stock Statistics & Valuation Metrics

Actinogen Medical has a market cap or net worth of AU$101.62M. The enterprise value is AU$59.83M.

Actinogen Medical has 3,175,477,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Actinogen Medical ’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Actinogen Medical is ―. Actinogen Medical ’s PEG ratio is 0.00.

In the last 12 months, Actinogen Medical had revenue of 5.49M and earned -14.73M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -7.56M and capital expenditures -38.02K, giving a free cash flow of -7.59M billion.

Actinogen Medical pays an annual dividend of ―, resulting in a dividend yield of ―

Actinogen Medical upcoming earnings date is Feb 19, 2026, TBA (Confirmed).

Actinogen Medical as a current ratio of ―, with Debt / Equity ratio of 1.21%

In the past 12 months, Actinogen Medical has paid -5.49M in taxes.

Actinogen Medical EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Actinogen Medical has AU$16.50M in cash and marketable securities with AU$3.26M in debt, giving a net cash position of AU$13.24M billion.

Gross margin is 100.00%, with operating margin of ―, and net profit margin of ―.

The average price target for Actinogen Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―